S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Route to Super Bowl dangerous for Mexico's avocado haulers
A gold storm is coming… (Ad)
Iraqi currency crash halts after meeting with U.S. official
Europe bans Russian diesel, other oil products over Ukraine
A gold storm is coming… (Ad)
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
EU migration impasse leaves many refugees out in the cold
Biden's State of the Union to tout policy wins on economy
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Route to Super Bowl dangerous for Mexico's avocado haulers
A gold storm is coming… (Ad)
Iraqi currency crash halts after meeting with U.S. official
Europe bans Russian diesel, other oil products over Ukraine
A gold storm is coming… (Ad)
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
EU migration impasse leaves many refugees out in the cold
Biden's State of the Union to tout policy wins on economy
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Route to Super Bowl dangerous for Mexico's avocado haulers
A gold storm is coming… (Ad)
Iraqi currency crash halts after meeting with U.S. official
Europe bans Russian diesel, other oil products over Ukraine
A gold storm is coming… (Ad)
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
EU migration impasse leaves many refugees out in the cold
Biden's State of the Union to tout policy wins on economy
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Route to Super Bowl dangerous for Mexico's avocado haulers
A gold storm is coming… (Ad)
Iraqi currency crash halts after meeting with U.S. official
Europe bans Russian diesel, other oil products over Ukraine
A gold storm is coming… (Ad)
How will EU ban and West's price cap on Russian diesel work?
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
EU migration impasse leaves many refugees out in the cold
Biden's State of the Union to tout policy wins on economy
CVE:ADK

DIAGNOS - ADK Stock Forecast, Price & News

C$0.34
-0.01 (-1.43%)
(As of 02/3/2023 05:19 PM ET)
Add
Compare
Today's Range
C$0.35
▼
C$0.36
50-Day Range
C$0.18
▼
C$0.39
52-Week Range
C$0.13
▼
C$0.43
Volume
52,500 shs
Average Volume
156,584 shs
Market Capitalization
C$23.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ADK stock logo

About DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Stock News Headlines

December 15, 2022 | finance.yahoo.com
DIAGNOS Provides Additional Information to the Closing of Private Placement
November 6, 2022 | reuters.com
ADK.V - Diagnos Inc | Stock Price & Latest News | Reuters
February 5, 2023 | Wall Street Watch Dogs (Ad)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
October 27, 2022 | finance.yahoo.com
DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
August 18, 2022 | finance.yahoo.com
DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
July 27, 2022 | finance.yahoo.com
DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics
June 7, 2022 | finance.yahoo.com
DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group
February 10, 2022 | finance.yahoo.com
DIAGNOS Successfully Completes ISO / MDSAP Audit
February 5, 2023 | Tradewins (Ad)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
October 28, 2021 | nz.finance.yahoo.com
DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA
August 17, 2021 | ca.finance.yahoo.com
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
July 20, 2021 | finance.yahoo.com
DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE
March 4, 2021 | finance.yahoo.com
DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology
March 3, 2021 | finance.yahoo.com
DIAGNOS Announces Stock Options Grants
February 26, 2021 | markets.businessinsider.com
DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update
February 4, 2021 | marketwatch.com
DIAGNOS Announces Further Deployment of its AI based CARA Technology in Saudi Arabia
September 15, 2020 | finance.yahoo.com
DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California
July 20, 2020 | www.bloomberg.com
DIAGNOS Closes Second and Final Tranche of Private Placement
July 14, 2020 | finance.yahoo.com
DIAGNOS Announces Signing of Service Agreement with the Colombian Telemedicine Centre
July 7, 2020 | www.baystreet.ca
Health-Care Stocks on the March
June 12, 2020 | www.barrons.com
Diagnos Inc.
April 27, 2020 | finance.yahoo.com
DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program
April 18, 2020 | www.bloomberg.com
DIAGNOS Inc/Canada
March 27, 2020 | www.globenewswire.com
DIAGNOS Announces Stock Options Grant
March 26, 2020 | www.globenewswire.com
DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the “US White ...
March 9, 2020 | www.globenewswire.com
DIAGNOS Announces Closing of Oversubscribed $2.1 Million Private Placement
February 17, 2020 | finance.yahoo.com
Trade Alert: Tristram Coffin At DIAGNOS Inc. (CVE:ADK), Has Just Spent CA$74k Buying Shares
See More Headlines
Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Company Calendar

Last Earnings
11/29/2022
Today
2/05/2023
Next Earnings (Estimated)
7/12/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Health Information Services
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
CVE:ADK
CUSIP
N/A
CIK
N/A
Web
www.diagnos.ca
Phone
+1-450-6788882
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
245.28
Current Ratio
0.82
Quick Ratio
0.68

Sales & Book Value

Annual Sales
C$577,486.00
Price / Sales
41.50
Cash Flow
C$0.01 per share
Price / Cash Flow
60.00
Book Value
C($0.02) per share
Price / Book
-20.29

Miscellaneous

Outstanding Shares
69,474,000
Free Float
N/A
Market Cap
C$23.97 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Andre Larente
    CEO, Pres & Exec. Director
  • Mr. Marc-André Massue
    VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles
    VP of Sales
  • Mr. Martin Beland
    Director of Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions













ADK Stock - Frequently Asked Questions

How have ADK shares performed in 2023?

DIAGNOS's stock was trading at C$0.28 at the beginning of 2023. Since then, ADK stock has increased by 23.2% and is now trading at C$0.35.
View the best growth stocks for 2023 here.

When is DIAGNOS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 12th 2023.
View our ADK earnings forecast.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (CVE:ADK) issued its quarterly earnings data on Tuesday, November, 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.15 million for the quarter, compared to the consensus estimate of $0.30 million.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?

DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of ADK stock can currently be purchased for approximately C$0.35.

How much money does DIAGNOS make?

DIAGNOS (CVE:ADK) has a market capitalization of C$23.97 million and generates C$577,486.00 in revenue each year.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882.

This page (CVE:ADK) was last updated on 2/5/2023 by MarketBeat.com Staff